American Century Companies’s Amneal Pharmaceuticals AMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.71M Buy
156,546
+34
+0% +$466 ﹤0.01% 2110
2026
Q1
$1.95M Buy
156,512
+62,229
+66% +$836K ﹤0.01% 2127
2025
Q4
$1.19M Buy
94,283
+1,209
+1% +$13.8K ﹤0.01% 2264
2025
Q3
$932K Buy
93,074
+24,943
+37% +$224K ﹤0.01% 2325
2025
Q2
$551K Buy
+68,131
New +$514K ﹤0.01% 2492
2024
Q4
Sell
-32,714
Closed -$272K 2888
2024
Q3
$272K Sell
32,714
-600
-2% -$4.69K ﹤0.01% 2684
2024
Q2
$212K Sell
33,314
-192,743
-85% -$1.22M ﹤0.01% 2712
2024
Q1
$1.37M Buy
226,057
+51,628
+30% +$291K ﹤0.01% 2023
2023
Q4
$1.06M Buy
174,429
+88,990
+104% +$396K ﹤0.01% 2036
2023
Q3
$361K Buy
85,439
+46,226
+118% +$172K ﹤0.01% 2390
2023
Q2
$122K Buy
39,213
+17,498
+81% +$37.3K ﹤0.01% 2649
2023
Q1
$29.5K Buy
21,715
+6,549
+43% +$13K ﹤0.01% 2652
2022
Q4
$30.2K Buy
+15,166
New +$34K ﹤0.01% 2567
2020
Q4
Sell
-64,707
Closed -$251K 1961
2020
Q3
$251K Buy
64,707
+260
+0.4% +$1.11K ﹤0.01% 1613
2020
Q2
$307K Sell
64,447
-67,413
-51% -$278K ﹤0.01% 1445
2020
Q1
$459K Buy
+131,860
New +$558K ﹤0.01% 1179
2019
Q2
Sell
-52,141
Closed -$739K 1265
2019
Q1
$739K Sell
52,141
-2,900
-5% -$38.3K ﹤0.01% 1083
2018
Q4
$745K Sell
55,041
-4,709
-8% -$84.9K ﹤0.01% 1083
2018
Q3
$1.33M Buy
+59,750
New +$1.26M ﹤0.01% 1075

Other funds holding AMRX

American Century Companies's AMRX Position: Q2 2026 in Review

American Century Companies increased its Amneal Pharmaceuticals (AMRX) stake by 0.02% in Q2 2026, buying an estimated $466 and bringing the position to 156,546 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2110.

American Century Companies first reported a position in AMRX in Q3 2018 and has held it in 19 quarters since. 288 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

  • American Century Companies held 156,546 shares of Amneal Pharmaceuticals worth $2.71M as of Q2 2026.
  • American Century Companies bought 34 Amneal Pharmaceuticals shares in Q2 2026, an estimated $466.
  • Amneal Pharmaceuticals made up ﹤0.01% of American Century Companies's portfolio in Q2 2026, its #2110 holding.
  • American Century Companies first reported a position in Amneal Pharmaceuticals in Q3 2018 and has held it in 19 quarters since.
  • 288 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on American Century Companies's 13F filing for Q2 2026, filed 12 Aug 2026.